Katy Beckermann, Assistant Professor of Medicine in the Division of Hematology and Oncology, Department of Medicine, at Vanderbilt University Medical Center, shared on X:
“Excited to share this case report led by the brilliant Paulo Amaral! It highlights the role of belzutifan in treating rare mutation VHL congenital-related polycythemia, showcasing its efficacy and safety.”
Von Hippel-Lindau syndrome-related congenital polycythemia and response to belzutifan
Authors: Paulo Siqueira do Amaral, Sanjay R. Mohan, Kathryn E. Beckermann
